EGFR and squamous cell carcinoma: Moreover, gigantoxin Ι is capable of binding to epidermal growth factor receptor (EGFR) and, therefore, induces morphological changes (rounding of the cells) and tyrosine phosphorylation of the EGFR in cells (was shown using epidermoid carcinoma A431 cell line) [68].